Prs34 - Cost and Drug Utilization Trends in Inhaled Corticosteroids/Long-Acting Beta Agonists (Ics/Laba) Fixed-Dose Combinations in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2428
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Addition of Long-Acting Beta-Agonists to Inhaled Corticosteroids for Chronic Asthma in Children

2009English

Addition of Long-Acting Beta2-Agonists to Inhaled Corticosteroids Versus Same Dose Inhaled Corticosteroids for Chronic Asthma in Adults and Children

Cochrane Database of Systematic Reviews
2010English

Seventeen-Year Nationwide Trends in Use of Long-Acting Bronchodilators and Inhaled Corticosteroids Among Adults: A Danish Drug Utilization Study

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Prs71 - Wasteful Healthcare Spending on Medication Oversupply in Routine Uses of Combined Inhaled Corticosteroid and Long-Acting Beta2-Agonists (Ics/Laba) Inhalers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Combination Long-Acting Β-Agonists and Inhaled Corticosteroids Compared With Long-Acting Β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease

JAMA - Journal of the American Medical Association
Medicine
2014English

Prs54 - Cost-Effectiveness Analysis of Reslizumab for Patients With Severe Eosinophilic Asthma Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting B2-Agonists in South Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Are All Fixed‐dose Laba/Lama Combinations Created Equal?

Respirology
PulmonaryRespiratory Medicine
2019English

A Retrospective Database Study Comparing Treatment Outcomes and Cost Associated With Choice of Fixed-Dose Inhaled Corticosteroid/Long-Acting Β2-Agonists for Asthma Maintenance Treatment in Germany

International Journal of Clinical Practice
Medicine
2008English

Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy